Plus   Neg

Carl Zeiss Meditec 9-month Revenue Down 5.8%

Carl Zeiss Meditec AG (CZMWF.PK) reported revenue of €967.9 million in the first nine months of fiscal year 2019/20, a decline of 5.8%, compared to €1,027.6 million.

Earnings before interest and taxes or EBIT decreased to €111.9 million from €184.2 million last year. The EBIT margin was 11.6% versus 17.9% a year ago.

"The effects of the COVID-19 pandemic impacted us significantly, particularly in the third quarter of fiscal year 2019/20. Although there has already been a slight recovery in some parts of APAC1 , the measures to contain the COVID-19 pandemic in Europe and North America had a marked effect on our customers and thus demand for our products," said Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG.

Based on the assumption that the markets would continue to recover and that no additional measures to contain the COVID-19 pandemic would be necessary, the company expects fiscal 2020 revenue to be around €1.3 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT